On Demand Webinar: Looking to develop a high quality, high titer manufacturing cell line?

Published: 24.06.2020

We have developed our SPOT™ technology alongside our proprietary CHO cell line to increase the cell line specific productivity (Qp) which facilitates high volumetric productivity at low VCD accompanied with a simple and efficient DSP process. Watch our on demand webinar now to find out more.

written by: Polpharma Biologics

Company News Published: 13.07.2020

Polpharma Biologics integrates Dutch based subsidiary, Bioceros, to offer the...

Gdansk, Poland and Utrecht, The Netherlands 13th July 2020. In 2016, Polpharma Biologics acquired Dutch bas...

Company News Published: 17.03.2020

All hands on deck! We all fight with COVID-19

The current situation caused by COVID-19 concerns us all. We had decided to help because we care. That’s wh...

Company News Published: 18.11.2019

First subjects in ph III study with PB006 (proposed Biosimilar to Natalizumab...

Our phase III clinical trial (PB006-03-01) entered into the stage when first patients were treated with stu...

Company News Published: 17.07.2019

32nd International Symposium on Preparative and Process Chromatography in Bal...

We participated in the 32nd International Symposium on Preparative and Process Chromatography in Baltimore.

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.

Related news

Let’s collaborate and deliver quality biosimilars together.